ID   CUTO-38
AC   CVCL_C8T4
SY   CUTO38; Colorado University Thoracic Oncology 38
DR   GEO; GSM7675385
DR   GEO; GSM7675386
DR   GEO; GSM7675387
DR   GEO; GSM7675388
DR   GEO; GSM7675389
DR   GEO; GSM7675390
DR   Wikidata; Q123031001
RX   DOI=10.1158/1538-7445.AM2020-3003;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1538-7445.AM2020-3003).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
RX   DOI=10.1158/1538-7445.AM2020-3003;
RA   Tyler L.C., Le A.T., Nijmeh H., Doebele R.C.;
RT   "MET mediates entrectinib resistance in ROS1 gene fusion positive
RT   NSCLC.";
RL   Cancer Res. 80 Suppl. 16:3003-3003(2020).
//